title: Multi-site TBT binding skews the inhibition of oligomycin on the mitochondrial Mg-ATPase in Mytilus galloprovincialis.
abstract: Tributyltin (TBT), a persistent lipophilic contaminant found especially in the aquatic environment, is known to be toxic to mitochondria with the F(1)F(0)-ATPase as main target. Recently our research group pointed out that in mussel digestive gland mitochondria TBT, apart from decreasing the catalytic efficiency of Mg-ATPase activity, at concentrations ≥1.0 μM in the ATPase reaction medium lessens the enzyme inhibition promoted by the specific inhibitor oligomycin. The present work aims at casting light on the mechanisms involved in the TBT-driven enzyme desensitization to inhibitors, a poorly explored field. The mitochondrial Mg-ATPase desensitization is shown to be confined to inhibitors of transmembrane domain F(0), namely oligomycin and N,N'-dicyclohexylcarbodiimide (DCCD). Accordingly, quercetin, which binds to catalytic portion F(1), maintains its inhibitory efficiency in the presence of TBT. Among the possible mechanisms involved in the Mg-ATPase desensitization to oligomycin by ≥1.0 μM TBT concentrations, a structural detachment of the two F(1) and F(0) domains does not occur according to experimental data. On the other hand TBT covalently binds to thiol groups on the enzyme structure, which are apparently only available at TBT concentrations approaching 20 μM. TBT is able to interact with multiple sites on the enzyme structure by bonds of different nature. While electrostatic interactions with F(0) proton channel are likely to be responsible for the ATPase activity inhibition, possible changes in the redox state of thiol groups on the protein structure due to TBT binding may promote structural changes in the enzyme structure leading to the observed F(1)F(0)-ATPase oligomycin sensitivity loss.
authors.affiliation: Department of Biochemistry G. Moruzzi, University of Bologna, Via Tolara di Sopra, Ozzano Emilia, Bologna, Italy.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Nesci
authors.forename: Vittoria
authors.initials: V
authors.lastname: Ventrella
authors.forename: Fabiana
authors.initials: F
authors.lastname: Trombetti
authors.forename: Maurizio
authors.initials: M
authors.lastname: Pirini
authors.forename: Alessandra
authors.initials: A
authors.lastname: Pagliarani
mesh_terms: D000465:Algorithms; D000818:Animals; D000975:Antioxidants / Q000378:metabolism / Q000633:toxicity; D001665:Binding Sites; D055162:Biocatalysis / Q000187:drug effects; D004024:Dicyclohexylcarbodiimide / Q000378:metabolism / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000378:metabolism / Q000633:toxicity; D007700:Kinetics; D008274:Magnesium / Q000378:metabolism; D025261:Mitochondrial Proton-Translocating ATPases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D049878:Mytilus / Q000201:enzymology*; D009840:Oligomycins / Q000378:metabolism / Q000633:toxicity*; D010084:Oxidation-Reduction / Q000187:drug effects; D011485:Protein Binding; D011794:Quercetin / Q000378:metabolism / Q000633:toxicity; D013438:Sulfhydryl Compounds / Q000378:metabolism; D014220:Trialkyltin Compounds / Q000378:metabolism / Q000633:toxicity*
chemical_list: D000975:Antioxidants; D004791:Enzyme Inhibitors; D009840:Oligomycins; D013438:Sulfhydryl Compounds; D014220:Trialkyltin Compounds; C011559:tributyltin; D004024:Dicyclohexylcarbodiimide; D011794:Quercetin; D025261:Mitochondrial Proton-Translocating ATPases; D008274:Magnesium